Silicon Legal represented Felicis Ventures as they joined Juvena’s $41 million oversubscribed Series A round.

Juvena Therapeutics is a biotechnology company unlocking the therapeutic potential of stem cell-secreted proteins and accelerating their development into life-saving therapeutics for chronic and age-related diseases.

The round was led by Mubadala Capital and Horizon Ventures, and in addition to Felicis, included participation from Bison Ventures, Manta Ray Ventures, IRONGREY, Alumni Ventures, Plum Alley, Transform VC, BoxOne Ventures, Intersect VC, Compound and various angel investors.

The Silicon Legal client team included Sarah Boulden, Gaurav Mathur, Natasha Hsieh, Kevin Morrissey, Tina Lee, Mike Perez and Chris Rosene.